- Home
- QNCX vs PRTS Comparison
QNCX vs PRTS Comparison
Compare QNCX & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- PRTS
- Stock Information
- Founded
- QNCX 2012
- PRTS 1995
- Country
- QNCX United States
- PRTS United States
- Employees
- QNCX N/A
- PRTS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- PRTS Auto & Home Supply Stores
- Sector
- QNCX Health Care
- PRTS Consumer Discretionary
- Exchange
- QNCX Nasdaq
- PRTS Nasdaq
- Market Cap
- QNCX 47.7M
- PRTS 51.3M
- IPO Year
- QNCX 2019
- PRTS 2007
- Fundamental
- Price
- QNCX $1.31
- PRTS $0.79
- Analyst Decision
- QNCX Strong Buy
- PRTS Buy
- Analyst Count
- QNCX 5
- PRTS 2
- Target Price
- QNCX $8.00
- PRTS $1.40
- AVG Volume (30 Days)
- QNCX 302.6K
- PRTS 399.7K
- Earning Date
- QNCX 08-12-2025
- PRTS 07-29-2025
- Dividend Yield
- QNCX N/A
- PRTS N/A
- EPS Growth
- QNCX N/A
- PRTS N/A
- EPS
- QNCX N/A
- PRTS N/A
- Revenue
- QNCX N/A
- PRTS $569,935,000.00
- Revenue This Year
- QNCX N/A
- PRTS $1.73
- Revenue Next Year
- QNCX N/A
- PRTS $5.48
- P/E Ratio
- QNCX N/A
- PRTS N/A
- Revenue Growth
- QNCX N/A
- PRTS N/A
- 52 Week Low
- QNCX $0.51
- PRTS $0.68
- 52 Week High
- QNCX $2.45
- PRTS $1.45
- Technical
- Relative Strength Index (RSI)
- QNCX 64.64
- PRTS 39.70
- Support Level
- QNCX $1.29
- PRTS $0.76
- Resistance Level
- QNCX $1.45
- PRTS $0.95
- Average True Range (ATR)
- QNCX 0.09
- PRTS 0.05
- MACD
- QNCX 0.03
- PRTS -0.01
- Stochastic Oscillator
- QNCX 76.74
- PRTS 15.79
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.